ResearcherUniversidad de La RiojaActive in the last 2 years
Rocío del Campo-Pedrosa
Matched on ORCID iD 0000-0003-0266-7856; OpenAlex author ID A5107817820. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2024: 2 papers · 2025: none · 2026: 1 paper
Papers 3
- Optimized chemotherapy sequence for metastatic pancreatic ductal adenocarcinoma patients: FOLFIRINOX followed by Gemcitabine plus nab-paclitaxel. Co-author DOI 10.1186/s12885-026-16391-7↗
- New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count. Co-author DOI 10.3389/fonc.2024.1411096↗
- Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count. Co-author DOI 10.3389/fonc.2024.1540165↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alfredo Martı́nez · 3 shared papers, 2024–2026 · strength 1.05
- Paper Optimized chemotherapy sequence for metastatic pancreatic ductal adenocarcinoma patients: FOLFIRINOX followed by Gemcit… DOI 10.1186/s12885-026-16391-7↗
- Paper New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and… DOI 10.3389/fonc.2024.1411096↗
- Paper Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and L… DOI 10.3389/fonc.2024.1540165↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.